Analysts have given a mixed reception to Axa's $15.3bn purchase of XL Group, with at least one warning that the takeover puts pressure on the IPO of the French insurer's US life and savings operations.
Analysts have given a mixed reception to Axa's $15.3bn purchase of XL Group, with at least one warning that the takeover puts pressure on the IPO of the French insurer's US life and savings operations.